
ACCME sees more criticism of pharma-sponsored continuing medication education
Labor unions want an end to pharma-sponsored CME
A board meeting of the Accreditation Council for Continuing Medical Education (Chicago) will receive today (July 16) a petition from Unite Here (New York), a major US/Canadian labor union group, calling for it to cease accepting funding from the pharma industry for CME, according to a press release issued by the group. “Prescription drugs, devices, and biologicals are a major factor in rising healthcare costs and the union is concerned doctors may be unduly influenced by contributions from Big Pharma to prescribe more expensive drugs when more affordable, generic alternatives are available.”
Unite Here cites the
The petition is just the latest in an ongoing campaign by Unite Here; it also sponsors a website, NoMoreDrugMoney.org. There is something of a history of labor union involvement in criticism of pharma commercial practices; for example, a Massachusetts labor union was involved in the $190-million
Even so, there seems to be a particular onus being borne by the pharma industry among labor unions. First, generic drug utilization is approaching 90% across the US healthcare system; the days when branded drugs were prescribed willy-nilly when equivalent generics are available have faded dramatically. Second, CME took a big hit in 2006 when ACCME, under widespread pressure, revamped its accreditation practices and made industry-sponsored CME more restrictive (details at ACCME’s site
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.





